Molnupiravir benefits outweigh risk among Covid patients: Experts
An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.
Jan 11, 2022, 10:44 AM ISTUK approves Pfizer COVID-19 vaccine for children aged 12-15, says it's safe for use
MHRA chief said that it would now be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Jun 04, 2021, 16:16 PM IST